A new study published in Developmental Psychology found that older preteen children (6th grade) are at risk of chronic partial sleep deprivation, leading to increased daytime sleepiness. Family stress, parental education, and age may contribute to this issue, highlighting the need for better sleep habits and support.
Researchers conducted a Phase II trial of adenoviral p53 gene transfer with radiation therapy, showing 29% of patients achieved local tumor control and 12 of 15 had no active cancer. The study demonstrated considerable promise for combined treatments, comparing favorably to a control rate of less than 20% in patients treated with radia...
A study published at ASCO suggests that treating cancer patients on clinical trials is not more expensive than standard treatment. The research found average charges of $57,542 for trial patients and $63,721 for control patients, highlighting the potential for increased access to high-quality care.
A Phase II trial found a 40% response rate with low-dose anti-VEGF combination therapy, compared to 24% for high-dose and 17% for chemotherapy alone. Median survival increased by 2 months with the low-dose treatment.
Researchers at Johns Hopkins presented Phase I study results for Taxoprexin DHA-paclitaxel, a novel taxane that tolerates high doses with minimal side effects. The drug delivers more therapeutic agent to tumor cells and less to healthy tissues, improving safety and effectiveness.